Great West Life Assurance CO Celldex Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $58 Billion
- Q4 2024
A detailed history of Great West Life Assurance CO transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 6,338 shares of CLDX stock, worth $141,083. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,338
Previous 6,338
-0.0%
Holding current value
$141,083
Previous $215,000
25.58%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CLDX
# of Institutions
200Shares Held
64.7MCall Options Held
1.72MPut Options Held
973K-
Wellington Management Group LLP Boston, MA8.98MShares$200 Million0.04% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$104 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$86.4 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.46MShares$77 Million9.64% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$74.2 Million1.99% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.04B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...